{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:00:32Z","timestamp":1787065232280,"version":"build-2736575974"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"suppl_5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11,15]]},"DOI":"10.1093\/cid\/civ600","type":"journal-article","created":{"date-parts":[[2015,11,9]],"date-time":"2015-11-09T19:33:10Z","timestamp":1447097590000},"page":"S473-S482","source":"Crossref","is-referenced-by-count":14,"title":["Costs of Neisseria meningitidis Group A Disease and Economic Impact of Vaccination in Burkina Faso"],"prefix":"10.1093","volume":"61","author":[{"given":"Ana\u00efs","family":"Colombini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Trotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Madrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andromachi","family":"Karachaliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Preziosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,11,9]]},"reference":[{"key":"key\n\t\t\t\t20171013230559_CIV600C1","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1016\/j.ijid.2009.08.013","article-title":"A hypothetical explanatory model for meningococcal meningitis in the African meningitis belt","volume":"14","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"suppl 5","key":"key\n\t\t\t\t20171013230559_CIV600C2","doi-asserted-by":"crossref","first-page":"S410","DOI":"10.1093\/cid\/civ597","article-title":"Meningococcal meningitis surveillance in the African meningitis belt, 2004\u20132013","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013230559_CIV600C3","first-page":"1022","article-title":"Serogroup A meningococcal conjugate vaccine coverage after the first national mass immunization campaign-Burkina Faso, 2011","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"suppl 2","key":"key\n\t\t\t\t20171013230559_CIV600C4","first-page":"B40","article-title":"Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience","volume":"30","year":"2012","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171013230559_CIV600C5","first-page":"123","article-title":"Meningococcal disease control in countries of the African meningitis belt, 2014","volume":"90","author":"World Health Organization","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20171013230559_CIV600C6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1473-3099(12)70168-8","article-title":"Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data","volume":"12","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20171013230559_CIV600C7","first-page":"394","article-title":"Neisseria meningitidis serogroup W, Burkina Faso, 2012","volume":"20","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20171013230559_CIV600C8","first-page":"57","article-title":"Meningococcal A conjugate vaccine: updated guidance, February 2015","volume":"90","author":"World Health Organization","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20171013230559_CIV600C9","article-title":"Control of epidemic meningococcal disease. WHO practical guidelines. 2nd edition","author":"World Health Organization","year":"1998"},{"key":"key\n\t\t\t\t20171013230559_CIV600C10","first-page":"577","volume":"89","author":"World Health Organization","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20171013230559_CIV600C11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0140-6736(99)03366-8","article-title":"Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171013230559_CIV600C12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/inthealth\/ihu062","article-title":"Time is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State, Nigeria","volume":"6","year":"2014","journal-title":"Int Health"},{"key":"key\n\t\t\t\t20171013230559_CIV600C13","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1086\/644623","article-title":"Costs for households and community perception of meningitis epidemics in Burkina Faso","volume":"49","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013230559_CIV600C14","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.1016\/j.vaccine.2011.05.058","article-title":"Costs and impact of meningitis epidemics for the public health system in Burkina Faso","volume":"29","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171013230559_CIV600C15","article-title":"Guide to identifying economic consequences of disease and injury","author":"World Health Organization","year":"2009"},{"issue":"suppl 5","key":"key\n\t\t\t\t20171013230559_CIV600C16","first-page":"S594","article-title":"Modeling long-term vaccination strategies with MenAfriVac in the African meningitis belt","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013230559_CIV600C17","author":"United Nations, Department of Economic and Social Affairs, Population Division","year":"2013"},{"issue":"suppl 1","key":"key\n\t\t\t\t20171013230559_CIV600C18","first-page":"A240","article-title":"Estimating costs of care for meningitis infections in low- and middle-income countries","volume":"33","year":"2015","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171013230559_CIV600C19","article-title":"Plan pluri-annuel strat\u00e9gique 2011\u20132015 du programme de vaccination du Burkina Faso","volume-title":"Burkina Faso","author":"Minist\u00e8re de la Sant\u00e9 du Burkina Faso","year":"2011"},{"key":"key\n\t\t\t\t20171013230559_CIV600C20","article-title":"Indicator database, GDP per capita","author":"World Bank"},{"key":"key\n\t\t\t\t20171013230559_CIV600C21","first-page":"15","article-title":"The value of vaccination","volume":"6","year":"2005","journal-title":"World Econ"},{"issue":"suppl 5","key":"key\n\t\t\t\t20171013230559_CIV600C22","first-page":"70","article-title":"Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus","volume":"18","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20171013230559_CIV600C23","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/j.vaccine.2010.11.090","article-title":"Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus influenzae type b vaccine","volume":"29","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171013230559_CIV600C24","first-page":"777","article-title":"Investing in children's health: what are the economic benefits?","volume":"83","year":"2005","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20171013230559_CIV600C25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s40273-013-0057-2","article-title":"The cost and public health burden of invasive meningococcal disease outbreaks: a systematic review","volume":"31","year":"2013","journal-title":"Pharmacoeconomics"},{"key":"key\n\t\t\t\t20171013230559_CIV600C26","first-page":"499","article-title":"Epidemiology of bacterial meningitis in Niamey, Niger, 1981\u201396","volume":"77","year":"1999","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20171013230559_CIV600C27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1473-3099(10)70048-7","article-title":"Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis","volume":"10","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20171013230559_CIV600C28","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1097\/INF.0b013e3182615297","article-title":"Costs of meningitis sequelae in children in Dakar, Senegal","volume":"31","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20171013230559_CIV600C29","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1016\/j.vaccine.2013.07.014","article-title":"Public \ufb01nance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis","volume":"31","year":"2013","journal-title":"Vaccine"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/61\/suppl_5\/S473\/20914425\/civ600.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T23:06:06Z","timestamp":1507935966000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/61\/suppl_5\/S473\/418389\/Costs-of-Neisseria-meningitidis-Group-A-Disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,9]]},"references-count":29,"journal-issue":{"issue":"suppl_5","published-online":{"date-parts":[[2015,11,9]]},"published-print":{"date-parts":[[2015,11,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/civ600","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,11,15]]},"published":{"date-parts":[[2015,11,9]]}}}